- Home
- PTGX vs SEM Comparison
PTGX vs SEM Comparison
Compare PTGX & SEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- SEM
- Stock Information
- Founded
- PTGX 2006
- SEM 1996
- Country
- PTGX United States
- SEM United States
- Employees
- PTGX N/A
- SEM N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- SEM Hospital/Nursing Management
- Sector
- PTGX Health Care
- SEM Health Care
- Exchange
- PTGX Nasdaq
- SEM Nasdaq
- Market Cap
- PTGX 2.3B
- SEM 2.4B
- IPO Year
- PTGX 2016
- SEM 2009
- Fundamental
- Price
- PTGX $38.75
- SEM $17.64
- Analyst Decision
- PTGX Strong Buy
- SEM Buy
- Analyst Count
- PTGX 8
- SEM 4
- Target Price
- PTGX $57.13
- SEM $36.67
- AVG Volume (30 Days)
- PTGX 528.6K
- SEM 885.2K
- Earning Date
- PTGX 02-21-2025
- SEM 02-20-2025
- Dividend Yield
- PTGX N/A
- SEM 2.15%
- EPS Growth
- PTGX N/A
- SEM N/A
- EPS
- PTGX 4.23
- SEM 1.23
- Revenue
- PTGX $434,433,000.00
- SEM $4,609,179,000.00
- Revenue This Year
- PTGX $445.33
- SEM N/A
- Revenue Next Year
- PTGX N/A
- SEM N/A
- P/E Ratio
- PTGX $9.16
- SEM $14.34
- Revenue Growth
- PTGX 624.05
- SEM N/A
- 52 Week Low
- PTGX $24.22
- SEM $14.14
- 52 Week High
- PTGX $48.89
- SEM $22.08
- Technical
- Relative Strength Index (RSI)
- PTGX 52.47
- SEM 35.63
- Support Level
- PTGX $37.50
- SEM $18.21
- Resistance Level
- PTGX $39.37
- SEM $19.54
- Average True Range (ATR)
- PTGX 1.32
- SEM 0.68
- MACD
- PTGX 0.16
- SEM -0.13
- Stochastic Oscillator
- PTGX 67.70
- SEM 34.40
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About SEM Select Medical Holdings Corporation
Select Medical Holdings Corp is a healthcare company that operates through four main segments: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and Concentra institutions. Critical illness recovery hospitals and rehabilitation centres are designed for patients requiring extended recovery time with medical services. These two sectors combined compose roughly half of the total revenue and include over 103 critical illness recovery hospitals and inpatient rehab facilities. The outpatient rehabilitation segment includes over 1,928 rehabilitation clinics. The Concentra segment includes over 540 occupational health centers and 147 onsite clinics. The company is headquartered in Pennsylvania, and it operates across the United States.